James Engelhart
2019
Compensation breakdown
| Bonus | $234,866 |
|---|---|
| Option Awards | $1,054,863 |
| Salary | $406,694 |
| Stock Awards | $849,520 |
| Other | $14,827 |
| Total | $2,560,770 |
Engelhart received $1.1M in option awards, accounting for 41% of the total pay in 2019.
Engelhart also received $234.9K in bonus, $406.7K in salary, $849.5K in stock awards and $14.8K in other compensation.
Rankings
In 2019, James Engelhart's compensation ranked 4,758th out of 13,971 executives tracked by ExecPay. In other words, Engelhart earned more than 65.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,758 out of 13,971 | 66th |
Division Manufacturing | 1,772 out of 5,701 | 69th |
Major group Chemicals And Allied Products | 617 out of 2,200 | 72nd |
Industry group Drugs | 519 out of 1,886 | 73rd |
Industry Pharmaceutical Preparations | 391 out of 1,398 | 72nd |
Pay ratio
| James Engelhart's Pay | $2,560,770 |
|---|---|
| Median Employee's Pay | $165,840 |
| Pay Ratio | 15to 1 |
In 2019, the annual total compensation of James Engelhart was $2,560,770.
The annual total compensation of the median employee at Biohaven Pharmaceutical Holding Co Ltd. was $165,840.
The ratio of James Engelhart's pay to the pay of median employee was therefore 15 to one.
Engelhart's colleagues
We found four more compensation records of executives who worked with James Engelhart at Biohaven Pharmaceutical Holding Co Ltd. in 2019.
2019
Vlad Coric
Biohaven Pharmaceutical Holding Co Ltd.
Chief Executive Officer
2019
William Jones
Biohaven Pharmaceutical Holding Co Ltd.
Chief Commercial Officer of Migraine & Common Diseases
2019
Kimberly Gentile
Biohaven Pharmaceutical Holding Co Ltd.
Senior Vice President, Clinical Operations
2019
Elyse Stock
Biohaven Pharmaceutical Holding Co Ltd.